UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2015 2015-07-31 Future report Set alerts
Q1 2015 2015-04-30 Future report Set alerts
Q4 2014 2015-01-31 0.00 0.00
Q3 2014 2014-10-31 0.00 0.00
Q2 2014 2014-07-31 0.00 0.19
Q1 2014 2014-05-06 0.00 -0.04
Q4 2013 2014-03-31 0.00 -0.04
Q3 2013 2013-11-05 0.00 -0.05
Q2 2013 2013-08-05 0.00 0.41
Q1 2013 2013-05-09 0.00 -0.72

Ratings

2013-09-18 Downgrade WBB Securities Buy to Hold $1.50
2013-03-19 Downgrade MLV & Co Hold to Sell $0.50
2013-02-25 Downgrade Stifel Nicolaus Buy to Hold
2013-02-25 Downgrade Robert W. Baird Outperform to Neutral $30 to $4
2013-02-25 Downgrade MLV & Co Buy to Hold
2012-05-21 Reiterated MLV & Co Buy $12 to $21
2012-05-08 Downgrade WBB Securities Strong Buy to Buy $9 to $17
2011-09-27 Upgrade WBB Securities Buy to Strong Buy $8
2011-03-11 Upgrade Auriga U.S.A Hold to Buy $5 to $10
2010-11-23 Upgrade MLV Capital Hold to Buy $12
2010-11-22 Initiated WBB Securities Buy $8
2010-10-11 Reiterated Auriga U.S.A Hold $9 to $5
2010-10-04 Reiterated Argus Buy $30 to $15
2010-06-21 Downgrade Auriga U.S.A Buy to Hold $36 to $9
2010-04-16 Initiated Auriga U.S.A Buy $36
2010-03-12 Initiated Piper Jaffray Overweight
2009-10-06 Upgrade Argus Hold to Buy $30
2008-09-24 Initiated Stanford Research Buy $29
2008-07-30 Downgrade UBS Buy to Neutral
2008-07-02 Initiated Robert W. Baird Outperform $25
1970-01-01
2013-09-18 Downgrade WBB Securities Buy to Hold $1.50
2013-03-19 Downgrade MLV & Co Hold to Sell $0.50
2013-02-25 Downgrade Stifel Nicolaus Buy to Hold
2013-02-25 Downgrade Robert W. Baird Outperform to Neutral $30 to $4
2013-02-25 Downgrade MLV & Co Buy to Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In AFFY 0 funds of 2186 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
CREDIT SUISSE AG/ 4.73%  (1774407) AFFY / PTCT / STRI / WD /
Orwin John A President and COO 0.20%  (76666) AFFY / ARRY / RLYP / SGEN /
Morris Arlene CEO 0.20%  (75000) AFFY / BIOD / MNOV / PTN / VIVE /
Cleveland Paul B EVP, Corp. Development and CFO 0.08%  (30000) AAVL / AFFY / ALDR / CLDN / SGMO /
Duliege Anne-Marie Chief Medical Officer 0.08%  (28125) AFFY / CCXI / RIGL /
Venteicher Robert SVP, Technical Operations 0.07%  (24994) AFFY /
CROSS HERB VP, Fin. & Chief Acct. Officer 0.06%  (21370) AFFY / KBIO / PDLI /
Knapp Jeffrey H Chief Commercial Officer 0.05%  (18125) ADMS / AFFY /

Comments